June 4, 2020

The Texas Drug Utilization Review Board met recently to make recommendations about clinical prior authorizations and the preferred drug list.

May 28, 2020

April 23, 2020

April 17, 2020

April 13, 2020

March 31, 2020

January 16, 2020

In 2019, the Texas State Legislature passed House Bill 2536 relating to drug cost transparency. It requires pharmaceutical drug manufacturers to report certain cost information on U.S. Food and Drug Administration-approved drugs sold in or into Texas.

Pages